GTAEXS617: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Condition	Trials
Breast cancer	1
Head and Neck Squamous Cell Carcinoma (HNSCC)	1
Hormone Receptor Positive [HR+] and Human Epidermal Growth Factor Receptor 2 Negative [HER2-] Breast Carcinoma	1
Lung cancer	1
Non-small Cell Lung Cancer (NSCLC)	1
Pancreatic Adenocarcinoma	1
Pancreatic cancer	1
Platinum-resistant High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers (HGSOC)	1
Triple Negative Breast Cancer (TNBC)	1

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
NCT05985655 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 30 locations

1 recruiting trial across 9 conditions.

No. For the full record, search ClinicalTrials.gov.